| WORCESTER, Mass. and TORONTO, Jan. 31, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (the "Company" or "Generex") (www.generex.com) (OTCBB: GNBT) today announced that it entered into a securities purchase agreement with certain institutional investors on January 31, 2012. The investors have agreed to purchase an aggregate of 2,000 shares of the Company's newly designated non-voting Series B 9% Convertible Preferred Stock ("convertible preferred stock") and warrants to purchase...continued GNBT Healthcare biotechnology novartis |
Tuesday, January 31, 2012
Generex Announces $2.00 Million Capital Investment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment